This intricate molecular interplay between KIAA1429, ARHGAP30, and the PI3K/AKT signaling pathway offers significant insights into the mechanistic pathways driving LUAD progression, highlighting potential targets for therapeutic intervention in this form of lung cancer. Here, VIRMA is linked to lung carcinoma.